Unveiling Hidden Costs: A Common Oversight

Imagine you're reviewing the annual pharmacy spend for a 700-employee company. The PMPM cost stands at $138, putting the total annual pharmacy expenditure at nearly $1.16 million. While this figure might appear typical, a deeper dive often reveals overlooked costs contributing to inflated Per Employee Per Month (PEPM) spend. In reality, the primary driver might not just be the specialty drugs making up 54% of the total spend. Instead, a complex web of factors, from rebates to formulary decisions, often masks the true cost.

Many benefits managers focus heavily on generic dispensing rates (GDR), aiming for the industry benchmark of 88-92%. Yet, even with a GDR of 91%, if specialty spend isn't managed properly, it can quickly erode savings. For instance, if your plan lacks proper step therapy protocols or fails to leverage biosimilars effectively, you're likely leaving significant savings on the table. Humira alternatives like Hadlima or Cyltezo can often save up to 70% compared to the brand-name drug, but without strategic implementation, such savings remain theoretical.

Rebates: The Double-Edged Sword

Rebates are often seen as a quick win for reducing pharmacy costs, but they can also disguise inefficiencies. While they provide a semblance of savings, they sometimes encourage the use of higher-cost drugs, as rebate contracts often favor expensive brands over cost-effective alternatives. For example, a CFO at a mid-sized tech firm was surprised to find that, despite receiving significant rebates, their net spend was still disproportionately high due to an overreliance on branded medications.

To optimize rebate benefits, it’s important to work closely with your PBM partners and ensure that rebate arrangements are truly in your favor. Focus on net cost rather than gross savings from rebates. It's also worth considering alternative models like pass-through pricing, which offer more transparency and align PBM incentives with your organization’s financial goals.

Specialty Drugs: The Quiet Budget Buster

Specialty drugs are notorious for budget overruns, often accounting for over half of an employer's total pharmacy spend. For instance, a 600-life manufacturing firm found that 35 out of 600 covered lives were using specialty medications, driving their annual pharmacy budget to $1.2 million. By establishing appropriate prior authorization requirements and leveraging biosimilar options, they managed to reduce their specialty drug costs by 20%, representing a savings of about $240,000 annually.

Critical to managing specialty spend is regular formulary reviews. Ensure your PBM is proactive in incorporating biosimilars as they become available. Also, consider integrating clinical management programs that align treatment options with the most cost-effective therapies. Partnering with clinical pharmacists can further help in tailoring these efforts to suit your employee population.

Overlooked Opportunities: Mail Order and Copay Assistance

Mail-order penetration often hovers between 15-25% but can be a strategic advantage when used correctly. A logistics company with 500 employees saw a $100,000 reduction in pharmacy costs when they increased their mail-order penetration to 30%. This shift not only lowered dispensing fees but also improved adherence and outcomes, translating into fewer medical claims down the line.

Similarly, exploring copay assistance programs can alleviate employee cost burdens while preserving plan assets. Programs such as the Lilly Insulin Value Program or Novo Nordisk Patient Assistance Program can significantly offset out-of-pocket costs for employees, leading to higher satisfaction and lower total plan spend. Communicating these opportunities effectively through your HR channels can maximize participation and savings.

To make informed decisions, access detailed drug pricing data through platforms like RxInfo.ai. Also, consider tapping into services like RxSaver.ai to identify potential savings through discount programs.

Addressing these areas with a strategic lens can uncover the lurking financial drains in your pharmacy benefits plan. By comprehensively evaluating and adjusting key elements such as rebate structures, specialty drug management, and supplemental cost-saving programs, you can achieve significant reductions in PEPM spend without sacrificing employee satisfaction or care quality. Keep these actionable insights at the forefront of your benefits strategy to keep costs transparent and sustainable.